trial

Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability

NCTId NCT04945278
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 34 (estimated)
Sponsored by University Hospital, Brest
Primary completion 2027-07-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
34 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2022-05-31
Primary completion
2027-07-31
Eligibility
ALL · 15 Years · 25 Years

Interventions & indications

Drugs
Double mirror device ALTER-EGOEASE test

Sponsors

University Hospital, BrestLead Sponsor

Investigators

1
Nathalie LAVENNEPrincipal Investigator

Sites

1 total
Bohars, France

Facts & assertions

4 sourced
Enrollment
34
Phase
NA
Primary Completion Date
2027-07-31
Status
RECRUITING
relationships
The graph out of here
drug
Double mirror device ALTER-EGO
drug
EASE test
drug
lead_sponsor
University Hospital, Brest
company
indication
Psychosis of Childhood Borderline
indication
Schizophrenia
indication
Psychotic Disorder
indication
investigator
Nathalie LAVENNE
person